SecurityMBII / Marrone Bio Innovations, Inc. (57165B106)
CEOMarrone Pamela G
IndustryAgricultural Chemicals
Institutional Owners43
Institutional Shares25,560,835 - 23.11%
Common Shares Outstanding110,588,949 shares (as of 2018-06-30)
Institutional Value$ 45,573,000 USD

Institutional Stock Ownership and Shareholders

MBII / Marrone Bio Innovations, Inc. Institutional Ownership

Marrone Bio Innovations, Inc. (NASDAQ:MBII) has 43 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 25,560,835 shares. Largest shareholders include Ardsley Advisory Partners, Waddell & Reed Financial Inc, BlackRock Inc., Primecap Management Co/ca/, Vanguard Group Inc, State Street Corp, Northern Trust Corp, Geode Capital Management, Llc, Icm Asset Management Inc/wa, and Morgan Stanley.
Marrone Bio Innovations, Inc. (NASDAQ:MBII) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-06 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 27,290 50
2018-08-14 13F-HR VANGUARD GROUP INC 1,045,047 2,251,404 115.44 2,090 4,142 98.18
2018-08-14 13F-HR WADDELL & REED FINANCIAL INC 24,714,892 4,714,892 -80.92 47,321 8,574 -81.88
2018-08-14 13F-HR STATE STREET CORP 10,800 807,871 7,380.29 22 1,486 6,654.55
2018-08-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 0 83,774 0 154
2018-08-08 13F-HR Spark Investment Management LLC 0 90,100 0 165
2018-08-14 13F-HR Invesco Ltd. 35,148 65
2018-08-14 13F-HR BARCLAYS PLC 20,200 4,004 -80.18 40 7 -82.50
2018-08-13 13F-HR PRIMECAP MANAGEMENT CO/CA/ 2,625,600 2,625,600 0.00 5,251 4,831 -8.00
2018-08-14 13F-HR CREDIT SUISSE AG/ 0 14,054 0 26
2018-08-08 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 0 101,700 0 188
2018-08-08 13F-HR Capital Planning Advisors, LLC 33,079 0 -100.00 66 0 -100.00
2018-08-14 13F-HR ARDSLEY ADVISORY PARTNERS 10,348,247 10,348,247 0.00 12,733 13,441 5.56
2018-07-30 13F-HR Raymond James Financial Services Advisors, Inc. 11,061 11,061 0.00 22 20 -9.09
2018-08-10 13F-HR Legal & General Group Plc 8,134 15
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 0 20,637 0 38
2018-08-14 13F-HR TEACHERS ADVISORS INC 0 75,039 0 138
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 0 77,711 0 142
2018-07-19 13F-HR Carroll Financial Associates, Inc. 2,000 2,000 0.00 4 3 -25.00
2018-07-30 13F-HR Taylor, Cottrill, Erickson & Associates, Inc. 15,000 15,000 0.00 30 28 -6.67
2018-08-18 13F-HR Laurel Wealth Advisors, Inc. 20,000 0 -100.00 40 0 -100.00
2018-08-14 13F-HR GUGGENHEIM CAPITAL LLC 17,851 0 -100.00 36 0 -100.00
2018-08-10 13F-HR CITIGROUP INC 0 10,778 0 20
2018-07-24 13F-HR MEEDER ASSET MANAGEMENT INC 524 964
2018-07-27 13F-HR PIEDMONT INVESTMENT ADVISORS LLC 947 2
2018-08-14 13F-HR MORGAN STANLEY 480 116,907 24,255.62 1 215 21,400.00
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 10,102 10,258 1.54 20 19 -5.00
2018-08-14 13F-HR DEUTSCHE BANK AG\ 0 86,966 0 159
2018-08-09 13F-HR BlackRock Inc. 77,806 2,694,051 3,362.52 156 4,957 3,077.56
2018-08-08 13F-HR Hanson McClain, Inc. 10,000 12,766 27.66 20 23 15.00
2018-08-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 0 83,489 0 154
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 0 21,100 0 39
2018-08-14 13F-HR ROYAL BANK OF CANADA 0 62 0 0
2018-07-19 13F-HR Aj Wealth Strategies, Llc 0 0 0 0
2018-08-02 13F-HR ICM ASSET MANAGEMENT INC/WA 250,000 460
2018-08-06 13F-HR RHUMBLINE ADVISERS 0 47,127 0 87
2018-08-13 13F-HR Ameritas Investment Partners, Inc. 4,928 9
2018-08-08 13F-HR AMERICAN INTERNATIONAL GROUP INC 0 35,540 0 65
2018-08-14 13F-HR JP Morgan Chase & Co 0 11,078 0 20
2018-08-02 13F-HR Genovese Burford & Brothers Wealth & Retirement Plan Management, LLC 3,200 3,200 0.00 6 6 0.00
2018-10-12 13F-HR BANK OF MONTREAL /CAN/ 388 377 -2.84 1 1 0.00
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 89,410 329,928 269.01 178 607 241.01
2018-08-14 13F-HR UBS Group AG 2,801 6,363 127.17 6 12 100.00
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA 0 1,785 0 3,284
2018-09-18 13F-HR/A NORTHERN TRUST CORP 31,936 512,232 1,503.93 64 943 1,373.44
2017-02-10 13F-HR BlackRock Fund Advisors 4,483 5,563 24.09 8 12 50.00
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 1,200 1,200 0.00 2 2 0.00
2018-08-14 13F-HR BlueCrest Capital Management Ltd 12,428 0 -100.00 25 0 -100.00

Related News Stories

Marrone Bio Innovations, Inc. (MBII) CEO Pam Marrone on Q2 2018 Results - Earnings Call Transcript

2018-08-15 seekingalpha
Good day, and welcome to the Marrone Bio Innovations Second Quarter 2018 Earnings Conference Call. Today's conference is being recorded. (0-4)

Can Lithium Help Albemarle (ALB) Beat Earnings Again in Q2?

2018-08-03 zacks
Albemarle Corporation (ALB - Free Report) will release its second-quarter 2018 results after the bell on Aug 7. Albemarle saw its profits surge in the first quarter, buoyed by strong gains in its Lithium unit. The company posted a profit of $131.8 million or $1.18 per share in the quarter, a roughly two-and-a-half fold jump on a year over year basis. Adjusted earnings of $1.30 per share for the quarter outstripped the Zacks Consensus Estimate of $1. (5-0)

Marrone Bio Innovations (MBII) Investor Presentation - Slideshow

2018-07-27 seekingalpha
The following slide deck was published by Marrone Bio Innovations, Inc. in conjunction with this event. (0-1)

Marrone Bio Innovations' (MBII) CEO Pam Marrone on Q1 2018 Results - Earnings Call Transcript

2018-05-12 seekingalpha
Marrone Bio Innovations, Inc. (NASDAQ:MBII) Q1 2018 Results Conference Call May 10, 2018 4:30 AM ET (0-3)

Marrone Bio (MBII) Q1 Earnings In Line, Revenues Rise Y/Y

2018-05-11 zacks
Marrone Bio Innovations, Inc. (MBII - Free Report) logged a net loss of $2.9 million or 4 cents per share in first-quarter 2018, narrower than a loss of $7.6 million or 31 cents per share a year ago. Loss per share for the reported quarter was in line with the Zacks Consensus Estimate. The narrower year-over-year loss was mainly due to a gain on the conversion of debt. (383-0)

CUSIP: 57165B106